Article
What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
PloS one - 1 Jan 2013
Bonnefond Amélie, Saulnier Pierre-Jean, Stathopoulou Maria G, Grarup Niels, Ndiaye Ndeye Coumba, Roussel Ronan, Nezhad Mohsen Azimi, Dechaume Aurélie, Lantieri Olivier, Hercberg Serge, Lauritzen Torsten, Balkau Beverley, El-Sayed Moustafa Julia S, Hansen Torben, Pedersen Oluf, Froguel Philippe, Charpentier Guillaume, Marre Michel, Hadjadj Samy, Visvikis-Siest Sophie
Abstract excerpt
Vascular endothelial growth factor (VEGF) is a key chemokine involved in tissue growth and organ repair processes, particularly angiogenesis. Elevated circulating VEGF levels are believed to play a role in type 2 diabetes (T2D) microvascular complications, especially diabetic retinopathy. Recently, a genome-wide association study identified two common single nucleotide polymorphisms (SNPs; rs6921438 and...
Topics
Join the communities discussing this publication.
